Pacific Shuanglin Bio-pharmacy Co., LTD (SHE:000403)

SHE:000403 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 1, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021	Jan 1, 2020
Market Capitalization	15,967	19,957	16,669	20,540	18,713	8,804
Market Cap Growth	16.64%	19.73%	-18.85%	9.77%	112.54%	28.28%
Enterprise Value	14,802	18,990	15,725	19,928	18,927	8,826
Last Close Price	21.84	26.84	22.33	27.43	37.19	17.58
PE Ratio	19.23	32.60	28.39	52.52	100.62	54.87
Forward PE	18.13	30.96	20.90	36.40	65.37	36.92
PS Ratio	5.60	8.57	6.93	10.42	17.82	9.62
PB Ratio	2.04	2.69	2.43	3.25	19.35	10.98
P/TBV Ratio	3.61	4.34	4.11	5.85	20.80	11.80
P/FCF Ratio	51.28	66.14	114.50	250.30	120.99	58.80
P/OCF Ratio	26.60	29.39	31.80	50.32	96.04	46.13
EV/Sales Ratio	5.20	8.15	6.54	10.11	18.03	9.64
EV/EBITDA Ratio	13.98	24.73	22.32	37.04	69.09	37.21
EV/EBIT Ratio	16.38	29.97	26.79	46.32	83.53	46.24
EV/FCF Ratio	47.54	62.94	108.02	242.85	122.38	58.95
Debt / Equity Ratio	0.08	0.07	0.05	0.02	0.39	0.14
Debt / EBITDA Ratio	0.56	0.64	0.52	0.26	1.39	0.46
Debt / FCF Ratio	1.92	1.64	2.57	1.72	2.46	0.74
Asset Turnover	0.33	0.28	0.32	0.45	0.71	0.71
Inventory Turnover	1.32	1.47	1.69	1.80	1.27	1.11
Quick Ratio	2.70	2.70	2.46	2.67	0.66	0.84
Current Ratio	4.07	3.72	3.18	3.85	1.35	1.77
Return on Equity (ROE)	11.08%	8.56%	8.91%	10.73%	20.66%	22.18%
Return on Assets (ROA)	6.53%	4.77%	4.87%	6.13%	9.60%	9.21%
Return on Capital (ROIC)	7.04%	5.23%	5.35%	6.88%	12.54%	13.93%
Return on Capital Employed (ROCE)	11.00%	8.20%	8.40%	6.70%	21.90%	23.00%
Earnings Yield	5.19%	3.07%	3.52%	1.90%	0.99%	1.82%
FCF Yield	1.95%	1.51%	0.87%	0.40%	0.83%	1.70%
Dividend Yield	1.35%	0.74%	0.36%	0.20%	-	0.38%
Payout Ratio	19.11%	10.91%	8.46%	3.08%	96.17%	90.13%
Buyback Yield / Dilution	0.20%	0.12%	-3.37%	-44.24%	-0.23%	0.00%
Total Shareholder Return	1.56%	0.87%	-3.01%	-44.03%	-0.23%	0.39%

Updated Oct 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.